GENERIC IMATINIB: A AFFORDABLE ALTERNATIVE?

The emergence of common imatinib represents a notable chance for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a considerable price tag, frequently presenting a challenge for accessibility for some individuals. C